BC Children's Hospital
Vancouver, British Columbia, V6H 3V4, Canada
Location status: Recruiting
Location contact
Anne-Mette Hermansen
CONTACT
NCT Number: NCT06869928
The Pain and Irritability of Unknown Origin (PIUO) Pathway is a clinical pathway that was developed to evaluate and manage unexplained pain and irritability for children with severe neurological impairments (SNI) who cannot verbally communicate 'where it hurts'. The investigators studied the usefulness of the Pathway with families and expert clinicians in 4 centres across Canada. The aim of this Phase 2 study is to determine whether this tool can transfer from hospital research centres into the community. The Pathway will be used by community pediatricians across British Columbia (BC) when they see patients with PIUO. The investigators want to know how well these pediatricians can follow the Pathway. The goal is to create a systematic, cohesive approach to enhance the clinical care for all children with complex medical needs experiencing PIUO.
Interested in participating?
Request Info6 month–18 year
All sexes
Interventional
Not applicable
Vancouver, British Columbia, V6H 3V4, Canada
Location status: Recruiting
Anne-Mette Hermansen
CONTACT
BACKGROUND: Many children with brain-based developmental disorders and their families, specifically those with SNI, experience on-going and difficult-to-treat PIUO. However, currently, no consensus exists among healthcare providers about how to best approach PIUO, which likely exacerbates the challenges in faced by parents in taking care of their children with SNI experiencing PIUO. The PIUO Pathway was developed to streamline pain management and care for these children, who are among the most vulnerable seen in any hospital or clinic. To-date, the PIUO Pathway has only been used by expert clinicians in complex care, palliative medicine, and pain medicine, and in tertiary pediatric care settings. Community pediatricians are not yet trained to use this tool, which limits access of such care to the tertiary care level and/or through access to specialist supports. Training front-line clinicians, specifically community pediatricians, to use the PIUO Pathway holds the potential to delivering sustained, effective, and quality community care that can better serve and reach this vulnerable population of Canadian children and families.
AIMS: To advance the assessment and treatment of PIUO in children with SNI and their families, the primary aims and respective research questions of this hybrid implementation-effectiveness study are:
Primary Implementation Aim 1: To determine the feasibility and effectiveness of, and factors that influence implementing the Pain Pathway. Specifically, do the implementation strategies show promise in facilitating the implementation of the Pain Pathway in community practice?
Primary Intervention Aim 2: To assess the effectiveness of the Pain Pathway intervention on relevant outcomes of children with SNI and their families. Specifically, does the Pain Pathway work to help manage PIUO for children with SNI presenting and their families when seen in a community practice?
METHODS
Study Design
The investigators will conduct a hybrid implementation-effectiveness feasibility study using a pre-post, quasi-experimental design. The study will run from 2023 to 2025. Since the Pain Pathway's effectiveness has not been tested previously in a community pediatric practice setting, the investigators selected a Type 2 hybrid effectiveness-implementation design to determine if the Pain Pathway can be feasibly implemented in a real-world (community-based) setting, while further testing the effectiveness of the intervention under a different condition. A hybrid design can offer a more rapid and efficient means to gather information on the effectiveness of the implementation and intervention, as well as to translate knowledge to practice.
Implementation will be guided by the National Implementation Research Network (NIRN)'s Active Implementation Frameworks. The Active Implementation Frameworks (AIF) is an evidence-based set of process frameworks used to facilitate the successful implementation of innovation into practice, including the delivery of evidence-based health services. The investigators will also refer to the NIRN Implementation Stages Planning Tool to support implementation development. Implementation will be conducted in an integrated, non-linear process across the four stages of the AIF: Stage 1 - Exploration; Stage 2 - Installation; Stage 3 - Initial Implementation; and Stage 4 - Full Implementation. Conducting implementation activities in a stepwise manner will allow the investigators to study the implementation in its entirety, including planning, preparing, training, evaluation, and sustainability.
The investigators will use the Theoretical Domains Framework (TDF) to identify barriers and facilitators to implementation. The investigators will also refer to the Behavioural Change Wheel (BCW) to identify priority mechanisms of action that underlie the selection of implementation strategies, which will target the priority barriers and facilitators that the investigators identify.
The Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework will be used to evaluation implementation processes and outcomes. RE-AIM is an integrated framework developed to support the adoption and sustainable implementation of evidence-based interventions in a wide range of health, public health, and community settings.
Intervention Components
The intervention being implemented consists of two components:
Hypothesized Mechanisms of Change and Implementation Strategies
The implementation strategies will be developed based on the results of the TDF-guided barrier and facilitator assessment of BC community paediatricians. The investigators will select empirically supported implementation strategies to fulfill each mechanism of action identified as relevant through the BCW, while targeting priority barriers and facilitators. The investigators hypothesize that the intervention functions of education, training, and modeling will likely form the foundation of the implementation strategies because the investigators anticipate that barriers to implementation will include a lack of knowledge of the Pain Pathway (knowledge - education) and how to apply it to practice (training), as well as the limited number of pediatricians with expertise in complex care, pediatric pain, and palliative medicine (lack of confidence in managing complex pain - modelling).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Pain Pathway Intervention Inclusion Criteria:
Pain Pathway Intervention Exclusion Criteria:
Implementation Participant Inclusion Criteria:
Implementation Participant Exclusion Criteria:
see arm description.
Time frame: End of the Pain Pathway, an average of 1 year to 18 months
Adoption of the Pain Pathway will be measured by completion rates, self-reported by community pediatricians.
Time frame: Baseline and end of the Pain Pathway, an average of 1 year to 18 months
Reach of the Pain Pathway will be measured by recruitment and retention rates of community pediatricians, self-reported by community pediatricians.
Time frame: End of the Pain Pathway, an average of 1 year to 18 months
Acceptability of the Pain Pathway will be measured by level of satisfaction (e.g., 1 = very unsatisfied; 7 = very satisfied) based on a Likert scale and self-reported by community pediatricians. Scores will be averaged and higher scores reflect higher levels of satisfaction/acceptability.
Time frame: End of the Pain Pathway, an average of 1 year to 18 months
Effectiveness of the PIUO Pain Pathway will be measured by proportion of children with SNI and families who received appropriate steps of investigation and treatment options based on following the steps of the PIUO Pain Pathway.
Time frame: Baseline and end of the Pain Pathway, an average of 1 year to 18 months
Number of participants whose pain and irritability (PIUO) scores are lower over time, measured by the parent-reported Pain Survey.
Time frame: Baseline and end of the Pain Pathway, an average of 1 year to 18 months
Family well-being, measured by standardized measures of well-being (e.g., PROMIS-57; 1 = unable to do; 5 = without any difficulty) based on parent/caregiver-report of their child and family unit (scoring min. = 8 and max. = 40). Scores are converted to T-scores (mean T-score = 50; standard deviation = 10).
Time frame: Baseline and end of the Pain Pathway, an average of 1 year to 18 months
Factors influencing implementation, including barriers and facilitators and health equity-related, will be measured by identification of these factors through survey and interviews with community pediatricians.
Contact information is provided by the study sponsor or research team.
Anne-Mette Hermansen, MA
CONTACT
604-875-2000 ext. 6909
Sharon Hou, PhD
CONTACT
604-875-2345 ext. 5300
University of British Columbia
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03464773
Irritability, Nervous System Diseases
Vancouver, British Columbia, Canada
View Trial DetailsNCT06246526
Chronic Pain, Nervous System Diseases
Charleston, West Virginia, United States
View Trial DetailsNCT07487610
Frailty, Nervous System Diseases
Edirne, Turkey (Türkiye)
View Trial DetailsNCT05492188
Central Nervous System Diseases, Nervous System Diseases
Charleston, South Carolina, United States
View Trial Details